IRIS - Res&Arch Institutional Research Information System - Research & Archive

FELICETTI, TOMMASO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.124
AS - Asia 1.433
EU - Europa 1.246
Continente sconosciuto - Info sul continente non disponibili 230
SA - Sud America 181
AF - Africa 42
OC - Oceania 3
Totale 5.259
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.017
SG - Singapore 716
IT - Italia 547
HK - Hong Kong 185
CN - Cina 184
RU - Federazione Russa 167
IE - Irlanda 155
BR - Brasile 128
VN - Vietnam 115
DE - Germania 65
FR - Francia 64
CA - Canada 57
KR - Corea 46
BD - Bangladesh 39
GB - Regno Unito 37
BE - Belgio 34
FI - Finlandia 32
SE - Svezia 31
IN - India 20
NL - Olanda 18
IQ - Iraq 16
PL - Polonia 16
ID - Indonesia 15
AR - Argentina 14
ES - Italia 13
JP - Giappone 13
ZA - Sudafrica 13
MX - Messico 12
TR - Turchia 11
UA - Ucraina 11
SA - Arabia Saudita 10
VE - Venezuela 10
CO - Colombia 9
PK - Pakistan 9
TT - Trinidad e Tobago 9
AT - Austria 8
CR - Costa Rica 8
IL - Israele 8
PT - Portogallo 8
RO - Romania 8
CL - Cile 7
CZ - Repubblica Ceca 7
EC - Ecuador 7
PH - Filippine 6
SC - Seychelles 6
UZ - Uzbekistan 6
CH - Svizzera 5
PR - Porto Rico 5
TN - Tunisia 5
AZ - Azerbaigian 4
CW - ???statistics.table.value.countryCode.CW??? 4
EE - Estonia 4
GT - Guatemala 4
LB - Libano 4
RS - Serbia 4
ET - Etiopia 3
GP - Guadalupe 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
AO - Angola 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
EG - Egitto 2
HR - Croazia 2
LK - Sri Lanka 2
LT - Lituania 2
MY - Malesia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PE - Perù 2
PY - Paraguay 2
QA - Qatar 2
SV - El Salvador 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
DK - Danimarca 1
GA - Gabon 1
GD - Grenada 1
HN - Honduras 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 5.028
Salva come PNG Salva come JPEG
Città #
Singapore 546
Perugia 320
San Jose 279
Chandler 221
Ashburn 182
Hong Kong 179
Dublin 155
Santa Clara 94
Council Bluffs 64
Boardman 59
Los Angeles 51
Moscow 46
New York 44
San Mateo 44
Seoul 44
Lauterbourg 40
Altamura 39
The Dalles 38
Beijing 36
Brussels 34
Ho Chi Minh City 34
Princeton 30
Medford 29
Lawrence 27
Dong Ket 25
Munich 22
Redmond 21
Dallas 20
Wilmington 20
Montreal 17
Orem 17
Phoenix 17
Piscataway 17
Spoleto 17
Hanoi 16
Redwood City 15
São Paulo 15
Rome 14
Brooklyn 13
Denver 12
Warsaw 12
Bologna 11
Turku 11
Andover 10
Atlanta 10
Buffalo 10
Des Moines 10
Helsinki 10
North Bergen 10
Nuremberg 10
Tokyo 10
Fremont 9
Hefei 9
San Giustino 9
Ann Arbor 8
Baghdad 8
Columbus 8
Houston 8
Lappeenranta 8
San José 8
West Jordan 8
Bucharest 7
Florence 7
London 7
Milan 7
Secaucus 7
Toronto 7
Amsterdam 6
Chicago 6
Dhaka 6
Mexico City 6
Norwalk 6
Olomouc 6
Riverbank 6
Saint Petersburg 6
Shanghai 6
Turin 6
Vienna 6
Chaguanas 5
Charlotte 5
Chennai 5
Guangzhou 5
Haiphong 5
Jakarta 5
Johannesburg 5
Naples 5
San Francisco 5
Seattle 5
Ankara 4
Cape Town 4
Da Nang 4
Guarda 4
Guatemala City 4
Hanover 4
Jacksonville 4
Jeddah 4
Medellín 4
Ninh Bình 4
Philadelphia 4
Querétaro 4
Totale 3.316
Salva come PNG Salva come JPEG
Nome #
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 219
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 168
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 163
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 154
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 149
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 148
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 143
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 138
Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi 136
Inhibition of Staphylococcus pseudintermedius Efflux Pumps by Using Staphylococcus aureus NorA Efflux Pump Inhibitors 135
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 125
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 124
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 124
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 122
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 120
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 119
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 116
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 115
Biofunctionalization of Poly(lactide-co-glycolic acid) Using Potent NorA Efflux Pump Inhibitors Immobilized on Nanometric Alpha-Zirconium Phosphate to Reduce Biofilm Formation 115
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 113
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 113
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 110
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 110
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 105
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 105
Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs 104
In Vitro and In Vivo Investigations into the Potential of Quinazoline and Quinoline Derivatives as NorA Efflux Pump Inhibitors Against Resistant Staphylococcus aureus Strains 101
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 100
Fighting Antimicrobial Resistance: Insights on How the Staphylococcus aureus NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised Molecular Dynamics (SuMD) and Molecular Docking Simulations 100
Functionalized sulfonyl anthranilic acid derivatives inhibit replication of all the four dengue serotypes 99
Building up efflux-mediated antimicrobial resistance in Staphylococcus pseudintermedius 98
Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance 94
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives 90
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate 88
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 84
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity 83
Triazolopyrimidine nuclei: privileged scaffolds for developing antiviral agents with a proper pharmacokinetic profile. 83
Microbial efflux pump inhibitors: A journey around quinoline and indole derivatives 83
An overview on small molecules acting as broad-spectrum agents for yellow fever infection 81
Virucidal Activity of the Pyridobenzothiazolone Derivative HeE1-17Y against Enveloped RNA Viruses 80
Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents 72
Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives 72
Role and regulation of membrane efflux pumps in Staphylococcus pseudintermedius clinical isolates 72
EVALUATION OF DRUG EFFLUX ACTIVITY IN ANTIMICROBIAL RESISTANT STAPHYLOCOCCUS PSEUDINTERMEDIUS CLINICAL ISOLATES 64
Protein-protein interactions by influenza polymerase subunits as drug targets 63
Targeting miRNA dysregulation with small molecules: The case of enoxacin 62
Optimized Inhibitors of MDM2 via an Attempted Protein-Templated Reductive Amination 57
Streamlined Synthesis and Structure–Activity Relationship Analysis of 2‐Amidothiophene‐3‐Carboxamides Targeting Influenza Polymerase PA‐PB1 Heterodimerization 38
New Pyridobenothiazolone Derivatives Display Nanomolar Pan‐Serotype Anti‐Dengue Virus Activity 34
2-Phenylquinolines Exhibit Anti-Severe Acute Respiratory Syndrome Coronavirus-2 Activity Through the Nonstructural Protein 13 Helicase Inhibition 28
Sulfonyl Anthranilic Acid Analogues Display Pan-Serotype Anti-Dengue Activity by Downregulating the Expression of Ribosomal Proteins Encoded by 5′-Terminal Oligopyrimidine Motif-Containing mRNA 23
Broad-Spectrum Antiviral Activity of Pyridobenzothiazolone Analogues Against Respiratory Viruses 17
Totale 5.259
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.189
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022249 0 0 0 0 13 2 44 69 29 16 30 46
2022/2023617 30 128 7 67 45 72 0 28 191 10 29 10
2023/2024339 20 54 16 5 8 12 93 7 14 26 36 48
2024/20251.047 15 64 40 88 83 95 217 87 147 44 111 56
2025/20261.998 126 126 101 214 262 176 359 110 215 153 98 58
2026/2027652 58 76 132 324 62 0 0 0 0 0 0 0
Totale 5.259